Contract HHSO100201700016C
Regeneron Pharmaceuticals Inc · Department Of Health And Human Services · September 29, 2022
Regeneron Pharmaceuticals Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 29, 2022 for $693.06 million (current value) of work in research and development in biotechnology. Performance is in Tarrytown, NY. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost-plus contract pricing. The most recent modification was on August 6, 2025. If all options are exercised, the contract could reach $756.42 million.
Contract details
- PIID
- HHSO100201700016C
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Tarrytown, NY
- First action
- September 29, 2022
- Latest action
- August 6, 2025
Description
NO COST MOD TO REVISE THE CONTRACT SECTIONS: ARTICLE B.4 AND F.4
Modification timeline
-
August 6, 2025Mod P00016 · Change Order$693.06M
-
September 29, 2022Mod P00011 · Supplemental Agreement For Work Within ScopeEBOLA THERAPEUTICS$693.06M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Transnetyx, Inc | Department Of Health And Human Services | June 25, 2026 | $18.3K |
| Deloitte Consulting Llp | Department Of Health And Human Services | June 18, 2026 | $50.0K |
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201700016C?
Contract HHSO100201700016C is a federal contract awarded to Regeneron Pharmaceuticals Inc by Department Of Health And Human Services on September 29, 2022 for $693.06 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 1 time since the base award.
Who won contract HHSO100201700016C?
Regeneron Pharmaceuticals Inc won contract HHSO100201700016C from Department Of Health And Human Services.
How much is contract HHSO100201700016C worth?
Contract HHSO100201700016C has obligated $0 to date but carries a potential ceiling of $756.42 million if fully funded and all options are exercised.